Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Danaher Corporation    DHR   US2358511028

Delayed Quote. Delayed Nyse - 12/19 04:03:37 pm
86.27 USD   +0.31%
12/12 DANAHER : Completes Acquisition of Nobel Biocare
12/12 DANAHER : Reaffirms 2014 Guidance and Initiates 2015 Outlook
12/11DJU.S. HOT STOCKS : Hot Stocks to Watch
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Danaher 1Q Profit Rises 43% On Strong Revenue Growth

04/19/2012 | 06:54am US/Eastern

Danaher Corp.'s (>> Danaher Corporation) first-quarter earnings rose 43% as the diversified manufacturer's revenue growth got a boost from acquisitions.

For the current quarter, Danaher forecast per-share earnings of 76 cents to 81 cents, including anticipated dilution of a penny from its recent deal to acquire X-Rite Inc. (XRIT). Analysts polled by Thomson Reuters expected per-share earnings of 82 cents.

The company narrowed its 2012 per-share earnings estimate to $3.25 to $3.35 from its previous range of $3.20 to $3.35. The new forecast includes 3 cents of anticipated dilution related to X-Rite.

Danaher has remained acquisitive, mostly focusing its efforts on medical technology, testing and measurement and dental equipment. The acquisition of Beckman Coulter last year for $5.78 billion was Danaher's largest deal and gives the company a stronger foothold in the growing diagnostics industry.

More recently Danaher reached a $478 million deal for color-measurement technology company X-Rite in a move Danaher expects will complement its Esko digital design capabilities and further its lead in the product identification industry.

President and Chief Executive H. Lawrence Culp Jr. said the company was encouraged by the quarter-to-quarter business improvement and expects that core growth will accelerate in the second quarter.

Danaher reported a profit of $612.9 million, or 86 cents a share, up from $429.4 million, or 63 cents a share, a year earlier. Earnings from continuing operations were up at 73 cents from 61 cents. Danaher in January had projected earnings of 66 cents to 71 cents.

Revenue increased 31% to $4.32 billion. Excluding acquisitions and currency fluctuations, revenue was up 1.5%

Analysts recently projected $4.33 billion.

Gross margin fell to 51.8% from 53.1%.

Shares closed Wednesday at $54.69 and were inactive premarket.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Danaher Corporation
React to this article
Latest news on DANAHER CORPORATION
12/12 DANAHER : Reaffirms 2014 Guidance and Initiates 2015 Outlook
12/12 DANAHER : Completes Acquisition of Nobel Biocare
12/11 DANAHER : Schedules Webcast of Investor and Analyst Meeting
12/11 DANAHER : Sets Date to Webcast Investor and Analyst Meeting
12/11DJU.S. HOT STOCKS : Hot Stocks to Watch
12/11DJDanaher Gives Rosy Earnings Outlook
12/11 DANAHER : Reaffirms 2014 Guidance and Initiates 2015 Outlook
12/11 DANAHER : Completes Acquisition Of Nobel Biocare
12/10 DANAHER : Announces Quarterly Dividend
12/09 DANAHER : GTCR Finalizes Sale of Devicor Medical Products to Leica Biosystems
Advertisement
Chart
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF